Impact of disease‐modifying therapies on humoral and cellular immune‐responses following SARS‐CoV‐2 vaccination in MS patients
Trümpelmann S, Schulte-Mecklenbeck A, Steinberg OV, Wirth T, Fobker M, Lohmann L, Lünemann JD, Wiendl H, Gross CC, Klotz L
Research article (journal) | Peer reviewedDetails about the publication
Journal: Clinical and Translational Science
Volume: 15
Page range: 1606-1612
Status: Published
Release year: 2022
DOI: 10.1111/cts.13256
Link to the full text: http://dx.doi.org/10.1111/cts.13256
Keywords: disease-modifying therapies, SARS-CoV-2, vaccination, multiple sclerosis, humoral and cellular immunity
Authors from the University of Münster
| Wirth, Timo | Department for Neurology |